Clinical Trials
54
Active:1
Completed:25
Trial Phases
4 Phases
Early Phase 1:1
Phase 2:1
Phase 4:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Not Applicable
26 (83.9%)Phase 4
3 (9.7%)Early Phase 1
1 (3.2%)Phase 2
1 (3.2%)The Effect of Walking Exercise in Patients With Chronic Obstructive Pulmonary Disease
Not Applicable
Recruiting
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2025-09-22
- Last Posted Date
- 2025-09-22
- Target Recruit Count
- 68
- Registration Number
- NCT07185659
- Locations
- 🇨🇳
Taipei Tzu Chi Hospital, New Taipei City, Xindian Dist., Taiwan
Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral Neuropathy
Not Applicable
- Conditions
- Breast Cancer Females
- First Posted Date
- 2025-09-03
- Last Posted Date
- 2025-09-11
- Target Recruit Count
- 40
- Registration Number
- NCT07151963
- Locations
- 🇨🇳
Taipei Tzu Chi Hospital, New Taipei City, Taiwan
Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Drug: Chemotherapy drugOther: Integrative Treatment (Chemotherapy + TCM)
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-07-31
- Target Recruit Count
- 200
- Registration Number
- NCT07096180
- Locations
- 🇨🇳
Buddhist Taipei Tzu Chi General Hospital, New Taipei City, Taiwan
Benefits of Jing-Si-Herbal-Tea in Bronchiectasis
Not Applicable
Completed
- Conditions
- Bronchiectasis
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Target Recruit Count
- 25
- Registration Number
- NCT06901557
- Locations
- 🇨🇳
Taipei Tzu Chi Hospital, New Taipei City, Xindan, Taiwan
ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression
Phase 4
Completed
- Conditions
- Asthma Patients
- Interventions
- Drug: Foster BDP/FormoterolDrug: Omalizimab
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-03-11
- Target Recruit Count
- 26
- Registration Number
- NCT06869382
- Locations
- 🇨🇳
Taipei Tzu Chi Hospital, New Taipei City, None Selected, Taiwan
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
News
No news found